IAS 16 Property, Plant and Equipment Last updated: March 2017 SCOPE Apply to: Property, plant and equipment (PPE) = tangible items held for use in production/supply of Does NOT apply when another Standard requires/permits different treatment: PPE classified as held for goods/services, rental to others, or administrative purposes AND expected use > 1 period. Includes sale (IFRS 5); biological assets related to agriculture (IAS 41); recognition and measurement of exploration construction of bearer plants, finished bearer plants accounted for under IAS 41. and evaluation assets (IFRS 6); and mineral rights/reserves. Recognition of leased PPE is based on IAS 17. RECOGNITION AND INITIAL MEASUREMENT Recognize and measure cost of item as an asset if: probable that future economic benefits associated with item will flow to entity AND cost can be measured reliably. PPE that enables entity to derive future economic benefits from related assets qualifies for recognition. Parts replaced at regular intervals → recognize new part if recognition criteria met AND derecognize the parts replaced. Spare parts, stand-by equipment, servicing equipment →recognize as PPE if meet definition of PPE, otherwise classify as inventory. Major inspections → recognize cost in carrying amount as replacement regardless if previous inspection was identified in initial transaction. Day-to-day servicing/maintenance/repairs (e.g., labour, consumables, small parts) → no additional economic benefits →recognized in P/L. Cost comprises: purchase price, including import duties and non-refundable purchase taxes, after deducting trade discounts and rebates. Directly attributable costs to bring asset to location/condition for intended operation. Initial estimate of cost to dismantle/remove item and restore site: Obligation incurred either when item is acquired (IAS 16) OR as consequence of having used it during a particular period (if to produce inventories IAS 2 applies, otherwise IAS 16). Apply IAS 37 to the obligation. Measure cost at: cash price equivalent (at recognition date) – if payment deferred beyond normal credit terms → interest recognized over credit period. Non monetary exchanges → measure at FV UNLESS transaction has no commercial substance/FV not reliable (see IAS 16 for more guidance). PPE held by lessee under finance lease (see IAS 17). Carrying amount may be reduced by government grant (see IAS 20). May include borrowing costs (see IAS 23). Directly Attributable Costs Employee benefits arising directly from construction/acquisition. Site prep, delivery, installation, assembly. Testing if functioning properly (less net proceeds on sale of samples produced). Professional fees. OTHER POINTS Costs NOT Included in PPE Cost of opening new facility, introducing new product or service (advertising/promotion). Staff training, admin and OH. Costs incurred while item capable of operation not yet brought into use. Initial operating losses while demand builds. Incidental costs/income (e.g., rent out of site). Apply IAS 36 to determine impairment and related accounting. See IAS 16 for disclosure. SUBSEQUENT MEASUREMENT REVALUATION MODEL: If FV reliably measurable→ carry at revalued amount LESS subsequent accumulated depreciation & Apply accumulated impairment. either Revalued amount = FV at date of revaluation. (to entire Revalue regularly so that carrying amount not materially different from FV at period end. class of Revalue entire class simultaneously – or on rolling basis within short period of time. PPE): Accumulated depreciation is either: adjusted to equal the difference between gross carrying amount and carrying amount of assets after considering accumulated impairment losses OR eliminated against gross carrying amount. COST MODEL: ↑ in carrying amount = recognize in other comprehensive income (under Revaluation Surplus Carry at cost heading) EXCEPT to extent reverses previous ↓/impairment recognized in P/L for same asset – then first recognized in P/L. LESS accumulated ↓ in carrying amount = recognize in P/L EXCEPT to extent that credit balance exists in revaluation surplus related to same asset → then first reduced to zero. depreciation & Revaluation surplus included in equity may be transferred directly to retained earnings when asset is impairment derecognized or some of the surplus may be transferred as the asset is used. DEPRECIATION Depreciation = Systematic allocation of depreciable amount over useful life. Recognize in P/L [unless included in carrying amount of another asset (e.g., depreciation of manufacturing equipment included in cost of inventory)]. Reflect pattern of usage/consumption (e.g., straight-line, diminishing balance, units of production). Componentization = part of PPE significant in relation to total cost → depreciate component part separately. Depreciable amount = cost (or amount substituted for cost) less residual value. Residual value = estimated amount currently obtainable (less disposal costs) if PPE were already of age and in condition expected at end of useful life – in practice often insignificant. Useful life = expected period over which asset is available for use OR expected units of production. Consider expected capacity and physical output; expected wear and tear; technical/commercial obsolescence; or legal or similar limits. Use judgment based on entity’s experience with similar assets. Review residual value, useful life and depreciation method at least every year-end → changes in estimate follow IAS 8. DERECOGNITION Derecognize carrying amount on disposal/when no future economic benefits expected from use/disposal Apply IAS 18 to determine disposal date on sale (or IAS 17 if finance lease). Gain/loss = net proceeds MINUS carrying amount. Recognize in P/L when asset derecognized (unless sale & leaseback see IAS 17). DO NOT classify as revenue, unless routinely sell items held for rental to others → transfer carrying amount to inventory and recognize revenue. Compensation from third parties for PPE that was impaired/lost/given up → recognized in P/L when receivable. This communication contains a general overview of the topic and is current as of March 31, 2017 The application of the principles addressed will depend upon the particular facts and circumstances of each individual case. Accordingly, this publication is not a substitute for professional advice and we recommend that any decisions you take about the application or not of any of the information presented be made in consultation with a qualified professional, who can address any variance that may be required to reflect your circumstances. Please contact your local MNP representative for customized assistance with the application of this material. MNP LLP accepts no responsibility or liability for any loss related to any person's use of or reliance upon this material. © MNP LLP 2017. All rights reserved.
© Copyright 2026 Paperzz